ICD-10 Code C84.17 | Sezary disease, spleen Symptoms, Diagnosis, Billing

Sezary disease is a rare type of cutaneous T-cell lymphoma characterized by erythroderma, lymphadenopathy, and circulating malignant T-cells. The involvement of the spleen indicates systemic disease progression. Accurate coding with ICD-10 Code C84.17 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex condition.

What is ICD-10 Code C84.17 for Sezary disease, spleen?

ICD-10 Code C84.17 specifically denotes Sezary disease with spleen involvement, indicating a more severe manifestation of this cutaneous T-cell lymphoma. This code should be utilized in clinical documentation when a patient presents with symptoms of Sezary disease and has confirmed splenic involvement, facilitating accurate billing and treatment planning.

ICD-10 Code C84.17 – Clinical Definition and Explanation of Sezary disease, spleen

Sezary disease is a leukemic form of cutaneous T-cell lymphoma that can progress to involve the spleen, leading to significant clinical implications. The condition arises from malignant T-lymphocytes that proliferate in the skin and may disseminate to lymphatic tissues, including the spleen, necessitating prompt medical intervention.

Key Clinical Features:

• Erythroderma with widespread skin involvement
• Lymphadenopathy with palpable lymph nodes
• Circulating atypical T-cells in peripheral blood
• Splenomegaly indicating systemic disease

ICD-10 Code C84.17 for Sezary disease, spleen – SOAP Notes & Clinical Use

ICD-10 Code C84.17 plays a crucial role in SOAP notes by documenting the patient's symptoms, assessment findings, and treatment plans. It is relevant in both acute and chronic care settings, ensuring comprehensive care and accurate billing for patients with Sezary disease involving the spleen.

What Does ICD-10 Code C84.17 for Sezary disease, spleen Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C84.17 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Sezary disease with spleen involvement. This code supports continuity of care, facilitates appropriate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C84.17 – Sezary disease, spleen

Sezary disease with spleen involvement requires urgent medical attention and may necessitate hospitalization for effective management.

Antibiotic Therapy:

• First-line: Methotrexate (duration varies based on response)
• Alternative: Gemcitabine (duration varies based on response)
• Consideration of systemic therapies such as photopheresis

Supportive Care:

• Management of skin symptoms with emollients and topical steroids
• Monitoring for secondary infections due to skin barrier disruption
• Psychosocial support for patients and families

Infection Control:

• Implement standard precautions to prevent infection spread
• Educate patients on hygiene practices to reduce infection risk
• Monitor for signs of opportunistic infections

How to Document Symptoms of Sezary disease, spleen (ICD-10 C84.17) in SOAP Notes

Subjective:

• Patient reports extensive skin redness and itching.
• History of lymph node swelling in the neck and axilla.
• Complaints of fatigue and weight loss over the past month.
• Previous diagnosis of cutaneous T-cell lymphoma.

Objective:

• Physical examination reveals erythroderma covering >80% of body surface.
• Palpable lymphadenopathy in cervical and axillary regions.
• Laboratory tests show elevated atypical T-cells in peripheral blood.
• Splenomegaly noted on abdominal examination.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Sezary disease, spleen (ICD-10 Code C84.17)

Assessment:

• Diagnosis: Sezary disease with splenic involvement, severe.
• ICD-10 Code: C84.17.
• Contributing factors: History of cutaneous T-cell lymphoma.
• Triggers: Possible environmental or genetic factors.

Plan:

• Initiate systemic therapy with methotrexate.
• Educate patient on skin care and infection prevention.
• Schedule follow-up in 4 weeks to assess treatment response.
• Consider referral to oncology for specialized management.

Treatment & Plan Section for ICD-10 Code C84.17 – Sezary disease, spleen

• First-line treatment includes systemic chemotherapy agents.
• Non-pharmacologic strategies involve skin care and infection prevention.
• Monitoring for treatment efficacy and side effects is essential.
• Follow-up appointments should be scheduled regularly to assess disease progression.

Using ICD-10 Code C84.17 for Sezary disease, spleen in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use C84.17 in appropriate clinical settings to support billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document any comorbidities or complications that may affect treatment.

Related ICD-10 Codes Often Used with Sezary disease, spleen

• C84.10 – Cutaneous T-cell lymphoma, unspecified type
• C84.11 – Mycosis fungoides
• C84.12 – Sezary syndrome
• C84.19 – Other cutaneous T-cell lymphomas

ICD-10 Code C84.17 in Medical Billing and Insurance for Sezary disease, spleen

ICD-10 Code C84.17 is critical for billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of C84.17.
• Ensure coding is consistent with the patient's clinical presentation.
• Use this code in conjunction with other relevant codes for comprehensive billing.
• Maintain clear records of treatment plans and patient responses.

Common CPT Pairings: